Restricted accessResearch articleFirst published online 1996-1
The Role of the Liver in the Pathogenesis of Hyperlipidemia in Patients with End-St Age Renal Disease Treated with Continuous Ambulatory Peritoneal Dialysis
SnidermanA.D., CianfloneK., KwiterovichPOJr., Hutchinson T, Barre P, Prichard S. Hyperapobeta-lipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis.Atherosclerosis1987; 65(3): 257–64.
2.
SnidermanA.D., BrownB.G., StewartF.F., CianfloneK.From familial combined hyperlipidemia to hyperapoB: unravelling overproduction of hepatic apo B lipoproteins.Current Opinion in Lipidology1992; 3(2): 137–42.
3.
ZilversmitD.B., NordestguardB.G.Comparison of arterial intimal clearances of LDL from diabetic and non-diabetic cholesterol-fed rabbits.Arteriosclerosis1989; 9: 176–83.
4.
DeGraafJ., HaklemmasH.L.M., HectorsM.P.C., DemackerP.N.M., HedricksJ.C.M., StalenhalfA.F.H.Enhanced susceptibility toin vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.Arteriosclerosis1991; 11: 298–306.
5.
Hurt-CamejoE., CamejoG., RosengrenB., LopezF., Wikland0, BondersG.Differential uptake ofproteo-glycan-selected subfractions of low density lipoprotein by human macrophages.J Lipid Res1990; 31: 1387–98.
6.
WeisserB., LocherR., DeGraafJ., MoserR., SachinidesA., VetterW.Low density lipoprotein subfractions increase thromboxane formation in endothelial cells.Biochem Biophys Res Commun1993; 192: 1245–50.
7.
CianfloneK., DahanS., MongeJ.C., SnidermanA.D.Pathogenesis of carbohydrate induced hypertriglyceridemia using HepG2 cells as a model system.Arterioscler Thromb1992; 12(3): 271–7.
8.
CianfloneK., VuH., ZhangZ., SnidermanA.D.Effects of albumin on lipid synthesis, apoB100 secretion, and LDL catabolism in HepG2 cells.Atherosclerosis1994; 107: 125–35.
9.
ZhangZ., SnidermanA.D., KalantD.The role of amino acids in apoB100 synthesis and catabolism in human HepG2 cells.J Biol Chem1993; 268(36): 26920–6.
